Published: Oct. 27, 2011
Updated: Oct. 28, 2011
Reporters & producers can visit Duke Medicine News and Communications for contact information.
TearScience’s LipiFlow Redefines Duke Eye Center’s Management of Dry Eye Patients
TearScience, Inc., a venture funded medical device company, today announced that Duke Eye Center, an academic research and education-based university eye care center, has purchased TearScience’s LipiFlow Thermal Pulsation System, a breakthrough treatment for evaporative dry eye disease and meibomian gland dysfunction.
Duke Eye Center focuses on the latest technology, research, and education to provide the most advanced patient care, including the management of dry eye disease.
“The LipiFlow system is a new approach to evaporative dry eye, a condition that is as common as cataracts,” according to Dr. Alan Carlson, chief of corneal and refractive surgery at Duke Eye Center. “LipiFlow is an advance in treating evaporative dry eye and could change the management of patients who have needed something more than we have been able to offer them until now.”
TearScience’s LipiFlow system is designed to treat blockages of the meibomian glands, which produce the lipids (oil) required for a healthy tear film, during a non-invasive procedure administered at an eye care office. LipiFlow uses a precise combination of heat and gentle pulsatile pressure applied to a patient’s eyelids to unblock obstructed glands, allowing the glands to resume the natural production of lipids.
In the U.S alone, an estimated $3.8 billion is spent annually directly in treating dry eye and that number is growing. Additionally, the indirect cost to society of lost productivity related to dry eye is estimated at $55.8 billion annually.
“Dry eye can be very debilitating,” added Carlson. “It can negatively impact a person’s lifestyle, particularly for those who suffer from moderate to severe dry eye. On average, LipiFlow provides symptomatic improvement for patients and improves meibomian gland secretions.”
Duke Eye Center specializes in treating some of the most challenging eye problems including dry eye, macular degeneration, glaucoma, and cataracts. The center provides state-of-the-art eye care to more than 130,000 patients annually.
Dr. Carlson is a leader in cataract, refractive, and corneal surgery having published more than 100 articles, book chapters, and instructional surgical videos highlighting his interest in the management and prevention of surgical complications. Carlson has also been named to several best doctor lists for 15 consecutive years.
“Dr. Carlson and the Duke Eye Center are well known for an innovative and caring approach to patient care,” said Tim Willis, president and CEO of TearScience. “We are delighted to have them as one of the first in the U.S. to implement our breakthrough solution for evaporative dry eye sufferers.”
TearScience’s technology platform is comprised of the LipiView Ocular Surface Interferometer and the LipiFlow Thermal Pulsation System. LipiView allows physicians to visualize the tear film of patients with dry eye disease.
Headquartered in Morrisville, North Carolina, TearScience has pioneered devices that provide significant clinical improvement in the treatment of evaporative dry eye. Of the more than 100 million dry eye sufferers worldwide, approximately 65 percent have evaporative dry eye, which is often caused by meibomian gland dysfunction (MGD) and a lipid deficiency of the eye’s natural tear film. The Tear Film and Ocular Surface Society (TFOS) workshop, involving two years of work by 50 leading experts from around the world, concluded that MGD is an under-estimated condition and is very likely the most frequent cause of dry eye disease. TearScience’s integrated, in-office system enables eye care professionals to effectively address a root cause of evaporative dry eye, obstructed meibomian glands. For additional information, visit www.TearScience.com.
Duke Eye Center seeks to preserve and restore eye sight by providing the highest quality and most complete health care to our patients. By sharing knowledge, skills and the latest breakthroughs in eye care with patients, we strive to improve ophthalmic treatments and patient outcomes. Duke Eye Center is dedicated to finding cures for blinding eye diseases.